Danielle E Arnold
Overview
Explore the profile of Danielle E Arnold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miranda M, Tsalatsanis A, Trotter J, Arnold D, Squire J, Kidd S, et al.
Clin Immunol
. 2024 Sep;
268:110364.
PMID: 39278553
No abstract available.
2.
McDonnell J, Cousins K, Younger M, Lane A, Abolhassani H, Abraham R, et al.
J Clin Immunol
. 2024 Apr;
44(4):86.
PMID: 38578389
Background: The CDC and ACIP recommend COVID-19 vaccination for patients with inborn errors of immunity (IEI). Not much is known about vaccine safety in IEI, and whether vaccination attenuates infection...
3.
Grunebaum E, Arnold D, Logan B, Parikh S, Marsh R, Griffith L, et al.
J Allergy Clin Immunol
. 2024 Jan;
153(5):1423-1431.e2.
PMID: 38290608
Background: P47phox (neutrophil cytosolic factor-1) deficiency is the most common cause of autosomal recessive chronic granulomatous disease (CGD) and is considered to be associated with a milder clinical phenotype. Allogeneic...
4.
Arnold D, Pai S
Curr Opin Pediatr
. 2023 Sep;
35(6):663-670.
PMID: 37732933
Purpose Of Review: Hematopoietic stem cell-based therapies, including allogeneic hematopoietic cell transplantation (HCT) and autologous gene therapy (GT), have been used as curative therapy for many inborn errors of immunity...
5.
Chandrasekaran P, Han Y, Zerbe C, Heller T, DeRavin S, Kreuzberg S, et al.
J Allergy Clin Immunol
. 2023 Sep;
152(6):1619-1633.e11.
PMID: 37659505
Background: Chronic granulomatous disease (CGD) is caused by defects in any 1 of the 6 subunits forming the nicotinamide adenine dinucleotide phosphate oxidase complex 2 (NOX2), leading to severely reduced...
6.
Leiding J, Arnold D, Parikh S, Logan B, Marsh R, Griffith L, et al.
Blood
. 2023 Aug;
142(24):2105-2118.
PMID: 37562003
Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by life-threatening infections and inflammatory conditions. Hematopoietic cell transplantation (HCT) is the definitive treatment for CGD, but questions remain regarding patient...
7.
Rajput R, Arnold D
Curr Hematol Malig Rep
. 2023 May;
18(4):89-97.
PMID: 37247092
Purpose Of Review: GATA2 deficiency is a haploinsufficiency syndrome associated with a wide spectrum of disease, including severe monocytopenia and B and NK lymphopenia, predisposition to myeloid malignancies, human papillomavirus...
8.
Arnold D, Chellapandian D, Parikh S, Mallhi K, Marsh R, Heimall J, et al.
J Clin Immunol
. 2022 Apr;
42(5):1026-1035.
PMID: 35445907
Granulocyte transfusions are sometimes used as adjunctive therapy for the treatment of infection in patients with chronic granulomatous disease (CGD). However, granulocyte transfusions can be associated with a high rate...
9.
Arnold D, Nofal R, Wakefield C, Lehmberg K, Wustrau K, Albert M, et al.
J Clin Immunol
. 2021 Sep;
42(1):36-45.
PMID: 34586554
X-linked inhibitor of apoptosis (XIAP) deficiency is an inherited primary immunodeficiency characterized by chronic inflammasome overactivity and associated with hemophagocytic lymphohistiocytosis (HLH) and inflammatory bowel disease (IBD). Allogeneic hematopoietic cell...
10.
Arnold D, Emoto C, Fukuda T, Dong M, Vinks A, Lane A, et al.
Bone Marrow Transplant
. 2021 Sep;
56(12):3029-3031.
PMID: 34548626
Alemtuzumab is used as part of reduced-intensity and reduced-toxicity transplant conditioning regimens for nonmalignant diseases. Prior studies identified an ideal target concentration range of 0.15-0.6 mcg/mL at day 0. However,...